Exactics Biotech
Exactics Biotech specializes in the development of rapid, affordable, and accurate at-home diagnostic tests for infectious diseases. The company employs a consumer-oriented design and scalable technology platforms to provide point-of-need diagnostics that aim to increase early disease detection and convenience. With a focus on lowering costs and minimizing development timelines, the company has established advanced laboratory operations and has developed solutions, beginning with Lyme disease, with plans for broader application.
Exactics Biotech
What We Do
A 15-minute at-home test that enables users to test ticks for bacterial pathogens associated with Lyme disease.
A 15-minute at-home test that enables users to test ticks for bacterial pathogens associated with Lyme disease.
Infectious Diseases
Diagnostics
Digital Health Technologies
Key People
News & Updates
Received second highest investment in CNVC history; won first place among undergraduate startups.
Secured first place, marking the team as the only undergraduate team to win both CNVC and SNVC.
Describes the founder's journey developing a 15-minute at-home Lyme disease test, team formation, and a $1.5 million fundraising round.
Covers the acquisition and setup of advanced lab equipment, the move to Hyde Park Labs, and the beginning of new research protocols.
In June, the team relocated and set up advanced laboratory equipment in Hyde Park Labs, facilitating the onset of new protocols for research expansion projects.
Won first place at UChicago’s College New Venture Challenge ($115,000 investment) and Social New Venture Challenge ($135,000 plus follow-on investments), closing the initial raise at $1.5 million.
Received second highest investment in CNVC history; won first place among undergraduate startups.
Secured first place, marking the team as the only undergraduate team to win both CNVC and SNVC.
Describes the founder's journey developing a 15-minute at-home Lyme disease test, team formation, and a $1.5 million fundraising round.
Covers the acquisition and setup of advanced lab equipment, the move to Hyde Park Labs, and the beginning of new research protocols.
In June, the team relocated and set up advanced laboratory equipment in Hyde Park Labs, facilitating the onset of new protocols for research expansion projects.
Won first place at UChicago’s College New Venture Challenge ($115,000 investment) and Social New Venture Challenge ($135,000 plus follow-on investments), closing the initial raise at $1.5 million.